CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
ExtruLub is a novel extrusion technology for medical devices that enhances catheter surfaces without compromising core properties. It aims to reduce friction, improve antimicrobial features, and enable targeted drug delivery, ultimately enhancing patient safety and reducing manufacturing costs.
ExtruLub is an innovative, disruptive extrusion technology applicable across a range of medical polymer resins, which has the ability to change the surface of a catheter without affecting core device properties.
The technology sits in the component sub-supply global market with an initial value of €564mn applicable across all catheter markets (combined value of $42.5bn globally by 2020).
From a functional perspective, ExtruLub has the ability to reduce surface friction, generate protective antim…
DIANIA TECHNOLOGIES LIMITED
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
